FDA-无菌药品生产指南(中英文版)介绍
VIP免费
Copyright SCI Version 1
Translated from / 译自:
Guidance for Industry
Sterile Drug Products
Produced by Aseptic Processing —
Current Good Manufacturing Practice
行业指南
无菌加工生产的无菌药品
—现行的生产质量管理规范(cGMP)
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Office of Regulatory Affairs (ORA)
September 2004
Pharmaceutical CGMPs
Copyright SCI Version 1
Guidance for Industry
Sterile Drug Products
Produced by Aseptic Processing —
Current Good Manufacturing Practice
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm
or
Office of Communication, Training and
Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
1401 Rockville Pike, Rockville, MD 20852-1448
http://www.fda.gov/cber/guidelines.htm.
(Tel) Voice Information System at 800-835-4709 or 301-827-1800
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Office of Regulatory affairs (ORA)
September 2004
Pharmaceutical CGMPs
Contains Nonbinding Recommendations
Copyright SCI Version 1
TABLE OF CONTENTS
I. INTRODUCTION............................................................................................................. 1
简介
II. BACKGROUND ............................................................................................................... 2
背景
A. Regulatory Framework ................................................................................................................. 2
法规架构
B. Technical Framework .................................................................................................................... 3
技术架构
III. SCOPE ............................................................................................................................... 4
适用范围
IV. BUILDINGS AND FACILITIES .................................................................................... 6
厂房和建筑
A. Critical Area – Class 100 (ISO 5) ................................................................................................. 8
关键区域– 100 级 (ISO 5)
B. Supporting Clean Areas .............................................................................................................. 11
辅助洁净区域
C. Clean Area Separation ................................................................................................................ 11
净化区的隔离
D. Air Filtration ................................................................................................................................ 12
空气过滤
1. Membrane ...................................................................................................................................... 13
膜过滤
2. High-Efficiency Particulate Air (HEPA) ....................................................................................... 14
高效颗粒空气过滤器
(HEPA)
E. Design ............................................................................................................................................ 16
设计
V. PERSONNEL TRAINING, QUALIFICATION, & MONITORING ........................ 20
人员的培训,资格认定和监控
A. Personnel ....................................................................................................................................... 21
人员
B. Laboratory Personnel .................................................................................................................. 25
实验室人员
C. Monitoring Program .................................................................................................................... 25
监控程序
VI. COMPONENTS AND CONTAINER/CLOSURES .................................................... 27
药品成分和容器/密封
A. Components .................................................................................................................................. 27
摘要:
展开>>
收起<<
CopyrightSCIVersion1Translatedfrom/译自:GuidanceforIndustrySterileDrugProductsProducedbyAsepticProcessing—CurrentGoodManufacturingPractice行业指南无菌加工生产的无菌药品—现行的生产质量管理规范(cGMP)U.S.DepartmentofHealthandHumanServicesFoodandDrugAdministrationCenterforDrugEvaluationandResearch(CDER)CenterforBiologicsEvaluation...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
GB∕T 25915.2-2021 洁净室及相关受控环境 第2部分:洁净室空气粒子浓度的监测
2024-04-17 999+ -
GB∕T 25915.3-2024洁净室及相关受控环境 第3部分:检测方法VIP免费
2024-08-09 127 -
(高清)GB∕T 25915.3-2024 洁净室及相关受控环境第3部分:检测方法VIP免费
2025-08-27 999+ -
GB∕T 16886.1-2025医疗器械生物学评价 第1部分 风险管理过程中生物学安全性评价的要求和通用原则(草案稿)VIP免费
2025-09-02 834 -
GB∕T 16886.11-2021 医疗器械生物学评价 第11部分:全身毒性试验VIP免费
2025-09-02 865 -
GB∕T 191-2025 包装储运图示标志(征求意见稿)VIP免费
2025-09-29 999+ -
GB∕T 19000-2016 质量管理体系 基础和术语(高清)VIP免费
2025-10-27 999+ -
GB∕T 19001-2016 质量管理体系要求
2025-10-27 999+ -
GB∕T 16292-2025 医药工业洁净室(区)悬浮粒子的测试方法VIP免费
2025-10-29 999+ -
GB∕T 16292《医药工业洁净室(区)悬浮粒子的测试方法》2010版和2025版对比分析(逐条对比)VIP免费
2025-10-30 579
作者:冒牌货
分类:专业资料
价格:60质量币
属性:102 页
大小:874.82KB
格式:PDF
时间:2026-01-07

